People needs to have absolutely recovered through the acute toxic consequences of all prior anti-cancer therapy and will have to satisfy the following minimum amount length from prior anti-cancer directed therapy ahead of enrollment. Experimental: Dose expansion_sub-populace 2_lower dose of niraparib MTDs and/or prospect RP2Ds for elimusertib utilised together with https://flagpeptide88765.blogaritma.com/26495630/trovafloxacin-mesylate-things-to-know-before-you-buy